World’s first vaccine relieves grass pollen allergy symptoms by at least 25%, study shows
Can't see this email? View it online
   
  January 23, 2018  
  Allergy  
  The latest Allergy news from News Medical  
 World’s first vaccine relieves grass pollen allergy symptoms by at least 25%, study showsWorld’s first vaccine relieves grass pollen allergy symptoms by at least 25%, study shows
 
Around 400 million people world-wide suffer in some form or other from a grass pollen allergy (rhinitis) - with the usual symptoms such as a runny nose, cough and severe breathing problems.
 
 
 ASIT biotech’s new article presents clinical results of gp - ASIT+ for treatment of grass pollen-induced rhinitisASIT biotech’s new article presents clinical results of gp - ASIT+ for treatment of grass pollen-induced rhinitis
 
ASIT biotech (ASIT - BE0974289218), a Belgian clinical-stage biopharmaceutical company specialized in immunotherapy products for the treatment of allergies, is publishing a new article in the prestigious science journal ALLERGY.
 
   New bug may reduce misery of hay fever sufferersNew bug may reduce misery of hay fever sufferers
 
A commonly-found weed that helps spread hay fever around Europe could be controlled by a new natural enemy.
 
   LJI study reveals key player that promotes skin inflammation in atopic dermatitisLJI study reveals key player that promotes skin inflammation in atopic dermatitis
 
Severe eczema, also known as atopic dermatitis, is a chronic inflammatory skin condition that is driven by an allergic reaction. In their latest study, researchers at La Jolla Institute reveal an important player that promotes skin inflammation in atopic dermatitis and the characteristic thickening of the skin.
 
   Beneficial bacteria on the skin of mice promotes immunity and accelerates wound healingBeneficial bacteria on the skin of mice promotes immunity and accelerates wound healing
 
Beneficial bacteria on the skin of lab mice work with the animals' immune systems to defend against disease-causing microbes and accelerate wound healing, according to new research from scientists at the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health.
 
 Scientists find how potential new eczema treatment could also alleviate asthma
 
Scientists find how potential new eczema treatment could also alleviate asthmaScientists from VIB-UGent have discovered insights for a possible new therapy for eczema that also reduces the severity of asthma
 
 
 New genomic tools provide better understanding of the human immune system
 
New genomic tools provide better understanding of the human immune systemWhen the body is under attack from pathogens, the immune system marshals a diverse collection of immune cells to work together in a tightly orchestrated process and defend the host against the intruders.
 
 
 Anti-inflammatory pill could help make vaccines more effective for the elderly
 
Anti-inflammatory pill could help make vaccines more effective for the elderlyBy identifying why skin immunity declines in old age, a UCL-led research team has found that an anti-inflammatory pill could help make vaccines more effective for elderly people.